Real-time enrollment status for this hypertrophic cardiomyopathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06481891 |
| Recruiting Status | Recruiting |
| Condition | Hypertrophic Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Lexicon Pharmaceuticals |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06481891 is currently recruiting participants. This clinical trial study for hypertrophic cardiomyopathy is actively seeking new participants at 24 locations across the United States. The study is sponsored by Lexicon Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06481891 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06481891 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.